Applications are now open for the 14th edition of the AboutPharma Digital Awards, the prize that since 2013 has highlighted the most innovative projects in the digital transformation of health. Pharmaceutical companies, medical device manufacturers, healthcare facilities, research centers, scientific societies, patient organizations, institutions, startups, providers, agencies and other players in the sector can submit their entries until December 10, 2026.
Over the years the Awards have tracked the evolution of digital health, moving from early applications designed for physicians and patients to the latest AI-based solutions, digital therapeutics, and tools that support clinical practice. Today the initiative serves as a privileged observatory of innovations that are redefining prevention, care, and the organization of health systems.
An Observatory of Digital Health Innovation
Launched in 2013 to highlight the best digital projects in healthcare, the award has progressively broadened its scope to keep pace with the evolution of technologies and the needs of patients, professionals, and health organizations. The growth of the AboutPharma Digital Awards reflects the evolution of digital health in recent years.
In the previous edition, 510 entries were received, submitted by 190 organizations, totaling 297 projects, evaluated by a multidisciplinary jury of 42 experts. These figures underscore the prize’s role as a privileged vantage point on technologies and organizational models that are set to impact clinical activity, patient management, and the efficiency of health services.
Artificial Intelligence, Training, and Clinical Practice
Among the innovations for the upcoming edition are categories dedicated to artificial intelligence, organized into three areas: communication and training, clinical practice and research, and business processes. Special emphasis is given to projects that support the physician’s work across the entire care pathway, using digital tools capable of enabling prevention, diagnosis, treatment planning, patient monitoring, decision support, and management of clinical data, along with platforms for advanced training and research projects based on big data and algorithms.
Of particular interest to GPs and specialists are the categories focused on updating and training of physicians, on supporting the medical profession, improving patient care and management, and on digital therapeutics and patient support programs — areas where digital technologies are helping to improve therapeutic adherence, care coordination, and continuity of care. In particular, the category dedicated to clinical practice and research aims to valorize AI-powered solutions applied to prevention, diagnosis, the definition of treatment pathways, patient monitoring, and the development of new scientific knowledge.
From Prevention to Patient Management
The 2027 edition features 19 project categories, spanning prevention and patient engagement to health communication, the digital transformation of organizations, and applications of artificial intelligence. The categories also include initiatives in prevention and wellness, outreach to citizens, patients, and health professionals, events in the life sciences space, innovation for pharmacists and pharmacies, organizational digital transformation, and ESG projects. There is ample room for initiatives that improve therapeutic adherence, enable more effective patient care, and promote new models of collaboration among health professionals, care facilities, and the general public.
Awards for Companies and Agencies
Alongside awards for individual projects, the AboutPharma Digital Awards 2027 include recognitions for organizations that stand out for their digital innovation strategy. They are complemented by the Best Company Awards, which include the Best Pharma Company Award (Gold, Silver, and Bronze) and the Best Medical Device Company Award (Gold). To compete in these categories, applicants must submit at least three projects across three different categories.
There are also Best Company Awards by therapeutic area, aimed at companies that nominate at least three initiatives related to the same clinical domain. The areas considered include cardiovascular diseases, neurology and mental health, oncology and hematology, infectious diseases, respiratory and allergic diseases, diabetes and obesity, nephrology, gastroenterology, dermatology, ophthalmology, pediatrics, and rare diseases. The awarded areas will be defined based on the submissions received.
How Projects Are Evaluated
Applications are evaluated based on three main criteria: Idea, which looks at originality and innovativeness; Execution, assessing quality of implementation and the ability to engage stakeholders; Results, measuring the achievement of objectives and the documented impact through indicators and realized outcomes. Applicants must describe the context, objectives, project characteristics, and the evidence supporting the results achieved.
How to Submit Your Candidacy
Applications must be submitted through the dedicated platform, following the guidelines laid out in the official regulations. To participate you will need to upload a PDF presentation of up to 15 slides, detailing the reference context, the project rationale, objectives, intended audience, implementation methods, and the results obtained, even if preliminary. Entries must be submitted by December 10, 2026.
Subscribe to Karla Miller
